Toggle navigation
Home
Search
Services
Blog
Contact
About
Medications Development for Stimulant Dependence (MDS)
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
Molecular epidemiology studies on the role of DNA repair breast cancer
Modeling Manganese Peroxidase - A Reactivity Study
The Zimbabwe-San Francisco HIV Prevention Trials Unit
US-Egypt Cooperative Research: Knowledge Discovery in Large Virtual Environments: Towards a New Approach for Solving Wayfinding Problem
Recently added grants:
Insights into the Molecular and Cellular Mechanisms governing Endothelial Function
Genetic Determinants of Lipidomic Variation and Their Role in CVD Risk
Investigating the Molecular Pathways of Cerebral Cavernous Malformation Maturation
Embryonic origins of endothelial heterogeneity
Lipoprotein Phosphorylation by Secretory Pathway Kinases
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research and Development Contracts (N01)
Project #
N01DA38824-21-0-2
Application #
7581649
Study Section
Project Start
2003-01-17
Project End
2008-01-16
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 DA
Medications Development for Stimulant Dependence (MDS)
/ University of California Los Angeles
$223,660
NIH 2007
N01 DA
Medications Development for Stimulant Dependence (MDS)
Ling, Walter /
$1,202,203
NIH 2007
N01 DA
/
NIH 2007
N01 DA
Medications Development for Stimulant Dependence (MDS)
/
Comments
Be the first to comment on this grant